Navigation Links
Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
Date:3/25/2013

kelly@vandapharma.com">jim.kelly@vandapharma.com

Media Contact:
Laney Cohen
Account Supervisor
Makovsky & Company, Inc.
(212)-508-9643
lcohen@makovsky.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Various statements in this release are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "project," "target," "goal," "likely," "will," "would," and "could," or the negative of these terms and similar expressions or words, identify forward-looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties.  Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: the inability to reach agreement with the FDA regarding Vanda's regulatory approval strategy or proposed path to approval for tasimelteon for the treatment of Non-24-Hour Disorder; Vanda's failure to obtain regulatory approval for tasimelteon for the treatment of Non-24-Hour Disorder or to comply with ongoing regulatory requirements; and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2012 which is on file with the SEC and available on the SEC's website at www.sec.gov.  In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results.  There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantia
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
2. Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results
3. Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint
4. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
5. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
6. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
7. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
8. Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012
9. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
10. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... WAYNE, N.J. , Dec. 19, 2014  In the Friday, ... , a 16-page supplement dedicated to Healthcare Information Technology (HIT) features ... innovation in Healthcare IT in partnership with several leading healthcare organizations. ... be distributed across several major metropolitan markets, such as ... Washington DC / Baltimore , Minneapolis ...
(Date:12/19/2014)... , December 19, 2014 TODAY, ... in the World announced the appointment of Peter ... Vonsée, as Chief Channels and Partner Officer. ... 2004 through to its acquisition by Oracle in 2011. ... at Geneva and subsequently Convergys, ...
(Date:12/19/2014)... Dec. 19, 2014  Newport Corporation (NASDAQ: ... Ph.D. has joined the company,s Board of Directors.  ... and a director of Evans Analytical Group, a ... and analytical services to companies in a wide ... joining Evans Analytical Group, Dr. Kadia spent nine ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... Columbia, Jan. 7, 2011 Enox Biopharma, Inc. CEO, John ... Emerging Company Finance Conference on Wednesday, January 12 at 8:10 ... Francis Drake Hotel in San Francisco. Dr. ... ability to embed nitric oxide into polymer based medical devices ...
... ANGELES, Jan. 7, 2011 MD+DI ( ... ( Medical Product Manufacturing News ), and OrthoTec, ... today announced session topics for the upcoming virtual event, ... 26, 2011, from 11am until 5pm Eastern time. ...
Cached Medicine Technology:Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference. 2Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices Offers Sessions on Orthopedic and Cardio Applications 2Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices Offers Sessions on Orthopedic and Cardio Applications 3
(Date:12/20/2014)... 2014 As Risperdal lawsuits ( ... U.S. courts, Bernstein Liebhard LLP notes the publication ... treated with the medication may experience elevated levels ... and lactation. The study, which appears in International ... who began treatment with risperidone, an antipsychotic medication ...
(Date:12/20/2014)... Francisco, CA (PRWEB) December 20, 2014 ... Social Innovation company just launched first birthday focused portal ... services, “MERRY BIRTHDAY MESSAGE” launched in both US and ... MERRY BIRTHDAY MESSAGE : http://merrybirthday.net/message/ , MERRY ... for everyone’s birthday around the world. , Features, Choose ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The aftermath of ... quite a stir, not only in Hollywood, but worldwide. ... 18th , the ripples of that attack are starting a ... jobs at risk. But they are not the only ... could be in for some embarrassing times ahead, agents and ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer ... coming Christmas. In the promotion, all buyers worldwide can ... have something special for the women who are looking ... our new collections of 2015 dresses have been unveiled ... greatly discounted prices. Visit our website now before they ...
(Date:12/20/2014)... Aliso Viejo, California (PRWEB) December 20, 2014 ... have announced the release of a new plugin for ... Pixel Film Studios. , “TranSlice Volume 5 allows users ... literally hand draw it.” Said Christina Austin, CEO of ... to add level of professionalism while maintaining an easy ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... study has found that brains of people who are victims ... The study, available in the current issue of Brain, ... de Montréal, the Montreal Neurological Institute and the Newcastle University ... to last a lifetime which impedes normal functioning people to ...
... 523 children and adolescents in the United States had ... a major national study called SEARCH for Diabetes in ... diabetes among youth under the age of 20 ever ... Ph.D., M.S., associate professor of epidemiology and prevention at ...
... sign of faster “biological ageing,” suggests research published ahead // ... ,The authors base their findings on a study of almost ... were female twins. ,X-rays of both hands were ... and a blood sample was taken to assess “biological ageing” ...
... A little-known antibiotic shows early promise as an anti-cancer ... most human tumors, // according to researchers at the ... ,Their findings appear in the Oct. 1 issue of ... gene believed to be over-expressed in cancer cells to ...
... better than non-contrast enhanced sonography, according to a ... Davis School of Medicine department of radiology in ... liver, spleen or renal injuries. Contrast-enhanced sonography depicted ... sonography revealed 11 (50%). ,“The main focus ...
... after years of dictatorship and war, Iraqi craniofacial and ... treating many of the most serious injuries caused by ... forward was last year's "Kuwait Plast 2005" meeting, in ... counterparts in a 5-day exchange of surgical knowledge and ...
Cached Medicine News:Health News:Understanding Reasons for Tone deafness 2Health News:One in 523 Children and Adolescents Have Diabetes 2Health News:One in 523 Children and Adolescents Have Diabetes 3Health News:Osteoarthritis May be Sign of Faster “Biological Ageing 2Health News:Antibiotic Inhibits Cancer Gene Activity 2Health News:Journal of Craniofacial Surgery Publishes Research by Iraqi Surgeons 2
Adsons bayonet forceps....
... Channel Implants, designed to accept ... surgeon with an excellent reconstructive ... and floor blowout defects. Each ... placement of one or more ...
... Rim is designed to augment ... the midface, including the inferior ... positioned in the hollow under ... Rim implant aids in restoring ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
Medicine Products: